杨舒媛, 张燕, 罗琰琨. 硫酸吲哚酚与慢性肾脏病肌少症机制的研究进展[J]. 临床肾脏病杂志, 2024, 24(6): 517-520. DOI: 10.3969/j.issn.1671-2390.2024.06.012
    引用本文: 杨舒媛, 张燕, 罗琰琨. 硫酸吲哚酚与慢性肾脏病肌少症机制的研究进展[J]. 临床肾脏病杂志, 2024, 24(6): 517-520. DOI: 10.3969/j.issn.1671-2390.2024.06.012
    Yang Shu-yuan, Zhang Yan, Luo Yan-kun. Research advances in the mechanisms of indoxyl sulfate and sarcopenia in chronic kidney disease[J]. Journal of Clinical Nephrology, 2024, 24(6): 517-520. DOI: 10.3969/j.issn.1671-2390.2024.06.012
    Citation: Yang Shu-yuan, Zhang Yan, Luo Yan-kun. Research advances in the mechanisms of indoxyl sulfate and sarcopenia in chronic kidney disease[J]. Journal of Clinical Nephrology, 2024, 24(6): 517-520. DOI: 10.3969/j.issn.1671-2390.2024.06.012

    硫酸吲哚酚与慢性肾脏病肌少症机制的研究进展

    Research advances in the mechanisms of indoxyl sulfate and sarcopenia in chronic kidney disease

    • 摘要: 慢性肾脏病肌少症主要发生在接受血液透析的终末期肾病患者中,病因有营养摄入不足、蛋白能量消耗、炎症细胞因子、氧化应激、胰岛素抵抗、尿毒症毒素等,其中蛋白质结合型尿毒症毒素硫酸吲哚酚是一种肠源性尿毒症毒素,难以通过透析清除,在慢性肾脏病患者体内蓄积,其可通过多种途径影响肌少症的发生。本文将对硫酸吲哚酚引起肌少症的机制进行综述。

       

      Abstract: Sarcopenia in chronic kidney disease (CKD) occurs mainly in patients with end-stage renal disease (ESRD) on hemodialysis. The potential causes are insufficient nutrition intake, protein and energy consumption, inflammatory cytokines, oxidative stress, insulin resistance and uremic toxins. Protein-bound uremic toxin phenol sulfate is an intestinal-derived uremic toxin accumulating in CKD patients. It is difficult to remove through dialysis. It affects the occurrence of sarcopenia through various ways. The review focused upon the mechanisms of sarcopenia caused by indoxyl sulfate.

       

    /

    返回文章
    返回